UTI advice to beat resistance

GPs need to alter prescribing for lower UTIs to reduce the spread of drug-resistant Escherichia coli strains, the Drugs and Therapeutics Bulletin has warned.

Bacteria that produce extended-spectrum beta-lactamases (ESBLs) are a known cause of healthcare-associated multi-drug-resistant infection, and are now spreading in the community.

The commonest ESBL-producing infections are UTIs caused by E coli. These are resistant to most antibacterial drugs used to treat UTIs.

Patients with lower UTI in areas where there is any risk of infection with a ESBL-producing organism should be treated with nitrofurantoin, which is effective against these strains.

GPletters@haymarket.com

DTB 2008

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus